Atea Pharmaceuticals Growth Metrics (2020-2022) | AVIR

Growth Metrics Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022
Growth Ratios
EBITDA Margin (QoQ) -3207.00-10031.0014,688.00
EBIT Margin (QoQ) -3207.00-8188.0013,055.00
EBT Margin (QoQ) -3207.00-8181.0013,042.00
Enterprise Value Growth (1y) 25,032.96%929.70%199.05%-100.82%-105.09%-109.72%-283.20%1,968.83%
Enterprise Value (QoQ) -575.29%8.99%2,568.73%64.33%-77.53%-89.13%-120.54%-915.35%57.11%-104.85%309.49%
FCF Margin (QoQ) -321.009,761.00-10813.00
Net Margin (QoQ) -4400.00-8848.0014,688.00
Operating Margin (QoQ) -3207.00-8188.0013,055.00
Return on Assets Growth (1y) 3.00-2.002.00
Return on Assets (QoQ) 1.00-1.0012.00-8.00-4.003.00
Return on Capital Employed Growth (1y) 4.00-4.00-2.00
Return on Capital Employed (QoQ) 2.00-1.0012.00-9.00-6.001.00
Return on Equity Growth (1y) 2.00-4.001.00
Return on Equity (QoQ) 1.00-2.0015.00-12.00-5.003.00
Return on Invested Capital (QoQ) 3.00